Cite
HARVARD Citation
Kocyigit, I. et al. (2017). Nebivolol can be used for combination therapy in patients with autosomal dominant polycystic kidney disease. Expert opinion on pharmacotherapy. p. 455. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kocyigit, I. et al. (2017). Nebivolol can be used for combination therapy in patients with autosomal dominant polycystic kidney disease. Expert opinion on pharmacotherapy. p. 455. [Online].